Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Deiss

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pediatric Diabetes|September 29, 2004
Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapyDorothee Deiss, Reinhard Hartmann, Julia Hoeffe, et al.
Hormone Research|April 30, 2002
Experience with insulin analogues in childrenThomas Danne, Dorothee Deiss, Werner Hopfenmüller, et al.
Diabetes Technology & Therapeutics|November 8, 2019
Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal CyclesKatherine S Tweden, Dorothee Deiss, Ravi Rastogi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Congenital central hypothyroidism due to homozygous thyrotropin beta 313 Delta T mutation is caused by a Founder effectHarald Brumm, Arne Pfeufer, Heike Biebermann, et al.
Diabetes Technology & Therapeutics|August 17, 2019
Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry StudyDorothee Deiss, Concetta Irace, Grace Carlson, et al.
Pediatric Diabetes|June 7, 2007
Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetesDorothee Deiss, Olga Kordonouri, Reinhard Hartmann, et al.
Journal of Diabetes Science and Technology|March 12, 2015
HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily InjectionsLutz Heinemann, Dorothee Deiss, Norbert Hermanns, et al.
Journal of Diabetes Science and Technology|October 30, 2009
Intensive Care Unit Insulin Delivery Algorithms: Why So Many? How to Choose?Garry M Steil, Dorothee Deiss, Judy Shih, et al.
Journal of Diabetes Science and Technology|January 23, 2019
Therapy Adjustments Based on Trend Arrows Using Continuous Glucose Monitoring SystemsRalph Ziegler, Simone von Sengbusch, Jens Kröger, et al.
Diabetes Care|July 29, 2003
A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetesThomas Danne, Jan Aman, Edith Schober, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pediatric Diabetes|September 29, 2004
Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapyDorothee Deiss, Reinhard Hartmann, Julia Hoeffe, et al.
Hormone Research|April 30, 2002
Experience with insulin analogues in childrenThomas Danne, Dorothee Deiss, Werner Hopfenmüller, et al.
Diabetes Technology & Therapeutics|November 8, 2019
Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal CyclesKatherine S Tweden, Dorothee Deiss, Ravi Rastogi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Congenital central hypothyroidism due to homozygous thyrotropin beta 313 Delta T mutation is caused by a Founder effectHarald Brumm, Arne Pfeufer, Heike Biebermann, et al.
Diabetes Technology & Therapeutics|August 17, 2019
Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry StudyDorothee Deiss, Concetta Irace, Grace Carlson, et al.
Pediatric Diabetes|June 7, 2007
Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetesDorothee Deiss, Olga Kordonouri, Reinhard Hartmann, et al.
Journal of Diabetes Science and Technology|March 12, 2015
HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily InjectionsLutz Heinemann, Dorothee Deiss, Norbert Hermanns, et al.
Journal of Diabetes Science and Technology|October 30, 2009
Intensive Care Unit Insulin Delivery Algorithms: Why So Many? How to Choose?Garry M Steil, Dorothee Deiss, Judy Shih, et al.
Journal of Diabetes Science and Technology|January 23, 2019
Therapy Adjustments Based on Trend Arrows Using Continuous Glucose Monitoring SystemsRalph Ziegler, Simone von Sengbusch, Jens Kröger, et al.
Diabetes Care|July 29, 2003
A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetesThomas Danne, Jan Aman, Edith Schober, et al.
Pageof 2